About: Extracorporeal membrane oxygenation for blastomycosis-related acute respiratory distress syndrome: a case series

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Extracorporeal membrane oxygenation for blastomycosis-related acute respiratory distress syndrome: a case series Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Extracorporeal membrane oxygenation for blastomycosis-related acute respiratory distress syndrome: a case series
Creator	Kumar, Anand Light, Bruce Freed, Darren White, Christopher Syed, • Ahmed, Zaki Bednarczyk, Joseph Bell, Dean Kethireddy, Shravan Singal, Rohit
Source	PMC
abstract	PURPOSE: Blastomyces dermatitidis is a dimorphic fungus endemic to North America capable of causing fatal respiratory failure. Acute respiratory distress syndrome (ARDS) complicates up to 10% of pulmonary blastomycosis in hospitalized patients and carries a mortality of 50-90%. This report describes the clinical course of four consecutive patients with blastomycosis-related ARDS treated with venovenous extracorporeal membrane oxygenation (ECMO) during 2009-2014. CLINICAL FEATURES: Four adults were referred from northwestern Ontario, Canada with progressive respiratory illnesses. All patients developed diffuse bilateral opacities on chest radiography and required mechanical ventilation within 6-72 hr. Patients satisfied Berlin criteria for severe ARDS with trough P(a)O(2)/F(i)O(2) ratios of 44-61 on positive end-expiratory pressure of 12-24 cm H(2)O. Wet mount microscopy from respiratory samples showed broad-based yeast consistent with B.dermatitidis. Despite lung protective ventilation strategies with maximal F(i)O(2) (patients A-D), neuromuscular blockade (patients A-D), inhaled nitric oxide (patients A and D), and prone positioning (patient D), progressive hypoxemia resulted in initiation of venovenous ECMO by hours 24-90 of mechanical ventilation with subsequent de-escalation of ventilatory support. In all four cases, ECMO decannulation was performed (7-23 days), mechanical ventilation was withdrawn (18-52 days), and the patients survived to hospital discharge (31-87 days). CONCLUSION: This report describes the successful application of ECMO as rescue therapy in aid of four patients with refractory blastomycosis-associated ARDS. In addition to early appropriate antimicrobial therapy, transfer to an institution experienced with ECMO should be considered when caring for patients from endemic areas with rapidly progressive respiratory failure.
has issue date	2015-04-08(xsd:dateTime)
bibo:doi	10.1007/s12630-015-0378-z
bibo:pmid	25851019
has license	no-cc
sha1sum (hex)	41407066bd81d0aeab3adb50cdfa0cf46782d98f
schema:url	https://doi.org/10.1007/s12630-015-0378-z
resource representing a document's title	Extracorporeal membrane oxygenation for blastomycosis-related acute respiratory distress syndrome: a case series
has PubMed Central identifier	PMC7100112
has PubMed identifier	25851019
schema:publication	Can J Anaesth
resource representing a document's body	covid:41407066bd81d0aeab3adb50cdfa0cf46782d98f#body_text
is schema:about of	named entity 'muscle rigidity' named entity 'anoxic' named entity 'neuromuscular blockade' named entity 'chest radiography' named entity 'ARDS' named entity 'amphotericin' named entity 'San Jose' named entity 'ECMO' named entity 'control group' named entity 'respiratory failure' named entity 'ARDS' named entity 'respiratory failure' named entity 'mechanical ventilation' named entity 'hemochromatosis' named entity 'ECMO' named entity 'critically ill patients' named entity 'ECMO' named entity 'ECMO' named entity 'ECMO' named entity 'PEEP' named entity 'blastomycosis' named entity 'pulmonary compliance' named entity 'dimorphic fungus' named entity 'inflammatory response' named entity 'ECMO' named entity 'lung' named entity 'life-threatening disease' named entity 'ARDS' named entity 'University of Manitoba' named entity 'fluid balance' named entity 'intravenous' named entity 'acid-base balance' named entity 'ARDS' named entity 'ECMO' named entity 'Addison's disease' named entity 'June, 2014' named entity 'extracorporeal membrane oxygenation' named entity 'refractory' named entity 'systemic corticosteroids' named entity 'blastomycosis' named entity 'bronchoalveolar lavage' named entity 'lung' named entity 'blastomycosis' named entity 'ECMO' named entity 'septic shock' named entity 'ARDS' named entity 'gas exchange' named entity 'lung' named entity 'extracorporeal membrane oxygenation' named entity 'ventilatory support' named entity 'tension pneumothorax' named entity 'ARDS' named entity 'gas exchange' named entity '3, 4' named entity 'refractory' named entity 'ECMO' named entity 'mechanical ventilation' named entity 'cysts' named entity 'northwestern Ontario' named entity 'statistical analysis' named entity 'ECMO' named entity 'APACHE II' named entity 'acute respiratory distress syndrome' named entity 'ECMO' named entity 'fraction of inspired oxygen' named entity 'de-escalation' named entity 'case series' named entity 'refractory' named entity 'fraction of inspired oxygen' named entity 'intensive care unit' named entity 'blastomycosis' named entity 'sputum production'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software